Data News > CMCSA, CSCO, CVS, CSX, JNJ showing five-day downward plunge

CMCSA, CSCO, CVS, CSX, JNJ showing five-day downward plunge

By KlickAnalytics Data Insights  |   July 23, 2024 10:47AM ET

Comcast Corp (CMCSA)

CMCSA is trading DOWN for the last 4 days, and it at trading at $37.23 with volume of 8,470,482 and a one day change of $-2.30 (-5.82%). Comcast Corp has a 52-week low of 36.43 and a 52-week high of $47.46. The business's 50-day moving average price is $38.49 and its 200 day moving average price is $40.80. The firm has a market cap of $155 million, a P/E ratio of 10.43, and a beta of 1.00.

Top news headlines for CMCSA

  • The headline numbers for Comcast (CMCSA) give insight into how the company performed in the quarter ended June 2024, but it may be worthwhile to compare some of its key metrics to Wall Street estimates and the year-ago actuals.
  • Comcast (CMCSA) came out with quarterly earnings of $1.21 per share, beating the Zacks Consensus Estimate of $1.11 per share. This compares to earnings of $1.13 per share a year ago.
  • Comcast Corporation (NASDAQ:CMCSA, ETR:CTP2) share price fell 1.4% in premarket trading after reporting weak performance in its studio and theme park operations. Its Peacock streaming service and a smaller-than-expected loss in broadband customers surprised on the upside.
  • CNBC's Joe Kernen reports on the company's quarterly earnings results.
  • The cable and entertainment company reports adjusted earnings of $1.21 a share, beating Wall Street estimates of $1.12.

  • For more information on CMCSA:
  • Historical Price Targets
  • Hiistorical Analyst Recommendations
  • Earning Price Impact Analysis
  • Seasonality Analysis

  • Cisco Systems, Inc. (CSCO)

    CSCO is trading DOWN for the last 4 days, and it at trading at $46.62 with volume of 2,442,419 and a one day change of $-0.20 (-0.43%). Cisco Systems, Inc. has a 52-week low of 44.95 and a 52-week high of $58.19. The business's 50-day moving average price is $46.74 and its 200 day moving average price is $48.47. The firm has a market cap of $189 million, a P/E ratio of 14.61, and a beta of 0.84.

    For more information on CSCO:
  • Historical Price Targets
  • Hiistorical Analyst Recommendations
  • Earning Price Impact Analysis
  • Seasonality Analysis

  • CVS Health Corp (CVS)

    CVS is trading DOWN for the last 4 days, and it at trading at $57.50 with volume of 1,673,411 and a one day change of $-0.83 (-1.42%). CVS Health Corp has a 52-week low of 52.77 and a 52-week high of $83.25. The business's 50-day moving average price is $59.61 and its 200 day moving average price is $68.00. The firm has a market cap of $73 million, a P/E ratio of 9.79, and a beta of 0.51.

    For more information on CVS:
  • Historical Price Targets
  • Hiistorical Analyst Recommendations
  • Earning Price Impact Analysis
  • Seasonality Analysis

  • CSX Corp. (CSX)

    CSX is trading DOWN for the last 4 days, and it at trading at $34.07 with volume of 1,560,078 and a one day change of $-0.44 (-1.28%). CSX Corp. has a 52-week low of 28.84 and a 52-week high of $40.05. The business's 50-day moving average price is $33.40 and its 200 day moving average price is $35.08. The firm has a market cap of $67 million, a P/E ratio of 18.79, and a beta of 1.20.

    For more information on CSX:
  • Historical Price Targets
  • Hiistorical Analyst Recommendations
  • Earning Price Impact Analysis
  • Seasonality Analysis

  • Johnson & Johnson (JNJ)

    JNJ is trading DOWN for the last 4 days, and it at trading at $152.17 with volume of 1,389,959 and a one day change of $-2.07 (-1.34%). Johnson & Johnson has a 52-week low of 143.13 and a 52-week high of $175.97. The business's 50-day moving average price is $148.11 and its 200 day moving average price is $153.33. The firm has a market cap of $371 million, a P/E ratio of 22.27, and a beta of 0.52.

    Top news headlines for JNJ

  • Johnson & Johnson might be the worst performing big pharma stock YTD, but there's upside possible for it in the remainder of 2024. Revenue growth guidance was upgraded and even with a downgrade in EPS guidance, the number is still expected to see a YoY increase. Its market multiples indicate the possibility of some uptick, and there are dividends to consider too.

  • For more information on JNJ:
  • Historical Price Targets
  • Hiistorical Analyst Recommendations
  • Earning Price Impact Analysis
  • Seasonality Analysis

  • This article was generated by KlickAnalytics data insight content engine.

    Disclaimer: the above is a summary showing certain market information. KlickAnalytics is not responsible for any data errors, omissions or other information that may be displayed incorrectly as the data is derived from various resources and more. Communications displaying market prices, data and other information available in this post are meant for purely for informational purposes only and are not intended as an offer or solicitation for the purchase or sale of any security. Please do your own research when investing. All investments involve risk and the past performance of a security, or financial product does not guarantee future results or returns. Keep in mind that while diversification may help spread risk, it does not assure a profit, or protect against loss in a down market.